BioMarin : BMRN

All BioMarin Articles

171 Articles

Lee Jackson | Jan 10, 2020 at 7:15 AM EST

5 Goldman Sachs Conviction List Stocks With Massive Upside Potential for 2020

These five top stocks spread across different sectors offer tremendous upside to the Goldman Sachs price objectives.

Jon C. Ogg | Nov 12, 2019 at 9:15 AM EST

Top Analyst Upgrades and Downgrades: Albermarle, Amgen, Applied Materials, Biogen, CRISPR, CrowdStrike, CSX, Kroger, Slack, Teva, Xerox and More

Tuesday's top analyst upgrades, downgrades and initiations included Albermarle, Amgen, Applied Materials, Biogen, CRISPR Therapeutics, CrowdStrike, CSX, Kroger, Slack, Teva…

Jon C. Ogg | Oct 30, 2019 at 9:02 AM EDT

Top Analyst Upgrades and Downgrades: AMD, Apple, Biomarin, Corning, EA, FireEye, Grubhub, Nordstrom, NXP, Shopify, Xerox and More

Wednesday's top analyst upgrades, downgrades and initiations included Advanced Micro Devices, Apple, Biomarin, Corning, Electronic Arts, FireEye, Grubhub, Nordstrom, NXP…

Jon C. Ogg | Oct 19, 2019 at 6:45 AM EDT

How Biotech and Big Pharma Have Upside Heading Into Earnings

Credit Suisse and Merrill Lynch made calls in the biotech and pharmaceutical space last week, ahead of coming earnings reports.

Jon C. Ogg | Oct 17, 2019 at 9:15 AM EDT

Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More

Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, CSX, IBM, Netflix, Occidental Petroleum, Whiting Petroleum, Amgen, Gilead Sciences,…

Jon C. Ogg | Jul 10, 2019 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: Acacia, Baidu, BioMarin, Boeing, BP, CSX, Deere, HCA, PepsiCo, Redfin, S&P, Trimble, Visa, Zillow and More

The top analyst upgrades, downgrades and initiations on Wednesday included Acacia Communications, Baidu, BioMarin Pharmaceuticals, Boeing, BP, CSX, Deere, HCA,…

Jon C. Ogg | Jul 3, 2019 at 12:10 PM EDT

Credit Suisse Best Ideas List Still Has 50% Implied Upside for 8 Stocks

With the three major stock indexes trading at or near all-time highs, many investors are scratching their heads about where…

Jon C. Ogg | May 23, 2019 at 11:40 AM EDT

Citigroup Sees Big Upside for 2 of the Largest Biotechs

Despite the wearing down of hepatitis C drugs and the political climate targeting drug prices, this analyst sees stabilization and…

Lee Jackson | Mar 20, 2019 at 7:20 AM EDT

5 Goldman Sachs Conviction List Stocks Have Gigantic Implied Upside

Shares of these five top companies offer tremendous upside to the Goldman Sachs price objective. While there is no guarantee…

Lee Jackson | Feb 6, 2019 at 7:05 AM EST

5 Stocks on Goldman Sachs Conviction List With Massive Upside Potential

These five top stocks across five sectors offer tremendous upside to the Goldman Sachs price objectives. Moving just halfway to…

Lee Jackson | Jan 31, 2019 at 7:40 AM EST

Why 6 Top Biotech Stocks Could Beat Wall Street Q4 Estimates

The biotech team at SunTrust feel that it would not be a major surprise to see these six top companies…

Jon C. Ogg | Jan 2, 2019 at 9:15 AM EST

Top Analyst Upgrades and Downgrades: Aflac, Akamai, BioMarin, Caesars Entertainment, CBS, Crocs, GW Pharma, Medtronic, Netflix, Sirius XM and More

The top analyst upgrades, downgrades and initiations seen on Wednesday included Aflac, Akamai, BioMarin, Caesars Entertainment, CBS, Crocs, GW Pharma,…

Lee Jackson | Dec 14, 2018 at 9:14 AM EST

Top Analyst Upgrades and Downgrades: Activision, BioMarin, Ciena, Delta Air, GlaxoSmithKline, Procter & Gamble, Regeneron, Tesla and More

The top analyst upgrades, downgrades and initiations seen on Friday included Activision Blizzard, BioMarin Pharmaceuticals, Ciena, Delta Air Lines, GlaxoSmithKline,…

Chris Lange | Oct 21, 2018 at 10:15 AM EDT

Top Biotech Earnings Reports to Watch This Week

Here is a preview of some of the world’s largest players in the health care sector reporting earnings this coming…

Jon C. Ogg | Jul 31, 2018 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Athenahealth, Illumina, Northrop Grumman, Square, Twitter, Yamana Gold and More

The top analyst upgrades, downgrades and other research calls from Tuesday include Athenahealth, Illumina, Northrop Grumman, Square, Twitter and Yamana…

1 2 3 4 5 6 … 12

BioMarin : BMRN

All BioMarin Articles

5 Goldman Sachs Conviction List Stocks With Massive Upside Potential for 2020

Top Analyst Upgrades and Downgrades: Albermarle, Amgen, Applied Materials, Biogen, CRISPR, CrowdStrike, CSX, Kroger, Slack, Teva, Xerox and More

Top Analyst Upgrades and Downgrades: AMD, Apple, Biomarin, Corning, EA, FireEye, Grubhub, Nordstrom, NXP, Shopify, Xerox and More

How Biotech and Big Pharma Have Upside Heading Into Earnings

Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More

Top Analyst Upgrades and Downgrades: Acacia, Baidu, BioMarin, Boeing, BP, CSX, Deere, HCA, PepsiCo, Redfin, S&P, Trimble, Visa, Zillow and More

Credit Suisse Best Ideas List Still Has 50% Implied Upside for 8 Stocks

Citigroup Sees Big Upside for 2 of the Largest Biotechs

5 Goldman Sachs Conviction List Stocks Have Gigantic Implied Upside

5 Stocks on Goldman Sachs Conviction List With Massive Upside Potential

Why 6 Top Biotech Stocks Could Beat Wall Street Q4 Estimates

Top Analyst Upgrades and Downgrades: Aflac, Akamai, BioMarin, Caesars Entertainment, CBS, Crocs, GW Pharma, Medtronic, Netflix, Sirius XM and More

Top Analyst Upgrades and Downgrades: Activision, BioMarin, Ciena, Delta Air, GlaxoSmithKline, Procter & Gamble, Regeneron, Tesla and More

Top Biotech Earnings Reports to Watch This Week

Top Analyst Upgrades and Downgrades: Athenahealth, Illumina, Northrop Grumman, Square, Twitter, Yamana Gold and More

A $620,000 Portfolio That Pays More Than the Average Social Worker’s Salary

Prediction: Pfizer Stock Will Double on This Date

SMH ETF Investors: Watch Hyperscaler Capex Guidance at July Earnings Calls

A $620,000 Portfolio That Pays More Than the Average Social Worker's Salary

The Average American Has Worked for 6 Employers and 23% Still Have Multiple Old Retirement Accounts, Fidelity's 2026 Study Finds

A $620,000 Portfolio That Pays More Than the Average Social Worker’s Salary

Prediction: Pfizer Stock Will Double on This Date

BioMarin : BMRN

All BioMarin Articles

5 Goldman Sachs Conviction List Stocks With Massive Upside Potential for 2020

Top Analyst Upgrades and Downgrades: Albermarle, Amgen, Applied Materials, Biogen, CRISPR, CrowdStrike, CSX, Kroger, Slack, Teva, Xerox and More

Top Analyst Upgrades and Downgrades: AMD, Apple, Biomarin, Corning, EA, FireEye, Grubhub, Nordstrom, NXP, Shopify, Xerox and More

How Biotech and Big Pharma Have Upside Heading Into Earnings

Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More

Top Analyst Upgrades and Downgrades: Acacia, Baidu, BioMarin, Boeing, BP, CSX, Deere, HCA, PepsiCo, Redfin, S&P, Trimble, Visa, Zillow and More

Credit Suisse Best Ideas List Still Has 50% Implied Upside for 8 Stocks

Citigroup Sees Big Upside for 2 of the Largest Biotechs

5 Goldman Sachs Conviction List Stocks Have Gigantic Implied Upside

5 Stocks on Goldman Sachs Conviction List With Massive Upside Potential

Why 6 Top Biotech Stocks Could Beat Wall Street Q4 Estimates

Top Analyst Upgrades and Downgrades: Aflac, Akamai, BioMarin, Caesars Entertainment, CBS, Crocs, GW Pharma, Medtronic, Netflix, Sirius XM and More

Top Analyst Upgrades and Downgrades: Activision, BioMarin, Ciena, Delta Air, GlaxoSmithKline, Procter & Gamble, Regeneron, Tesla and More

Top Biotech Earnings Reports to Watch This Week

Top Analyst Upgrades and Downgrades: Athenahealth, Illumina, Northrop Grumman, Square, Twitter, Yamana Gold and More

A $620,000 Portfolio That Pays More Than the Average Social Worker’s Salary

Prediction: Pfizer Stock Will Double on This Date

SMH ETF Investors: Watch Hyperscaler Capex Guidance at July Earnings Calls

Featured Reads

A $620,000 Portfolio That Pays More Than the Average Social Worker's Salary

The Average American Has Worked for 6 Employers and 23% Still Have Multiple Old Retirement Accounts, Fidelity's 2026 Study Finds